Gamunex-c 10 gram/100 ML vial 100ML
Ended Awarded
- Contract number
- SPE2DB25FRN90
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,221
Award facts
- Contract value 100% obligated
- $1,220.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,220.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 10 Gram/100 ML vials totaling 100 ML. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor serving military and veteran healthcare systems. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapy used to treat various immunological conditions and is a specialized pharmaceutical commodity within the defense medical supply chain. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, PA 19428. This transaction exemplifies the company's role as a primary pharmaceutical distributor for the Defense Health Agency and other federal healthcare systems, fulfilling essential medical supply requirements through the DLA's comprehensive global pharmaceutical support vehicle that enables flexible procurement of brand-name and generic medications, specialty pharmaceuticals, vaccines, and related medical supplies across multiple therapeutic domains worldwide.
Quick answers
Who was awarded contract SPE2DB25FRN90?
SPE2DB25FRN90 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FRN90 worth?
The government has obligated $1,221 on SPE2DB25FRN90.
Is contract SPE2DB25FRN90 an order under another contract?
Yes. SPE2DB25FRN90 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRN90 competed?
The extent of competition for SPE2DB25FRN90 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award